Frequently Asked Questions What is BPC-157 + TB-500
Protocol approach: frozen shoulder (adhesive capsulitis) Goal: Reduce capsular fibrosis, restore range of motion, manage pain Peptide approach: BPC-157: 300 to 500 mcg daily for anti-inflammatory and tissue healing properties TB-500: 500 to 750 mcg twice weekly for systemic anti-inflammatory and tissue remodeling Note on relaxin-2: While the most specifically targeted peptide for this condition, it remains largely in the research phase and is not widely available through standard channels Duration: Twelve to sixteen weeks (frozen shoulder has a prolonged natural course) Critical addition: Aggressive physical therapy within pain tolerance
Studies have shown that a deficiency in B12 can lead to neurological disorders, but supplementation, even without proven deficiency, has shown benefits in conditions like peripheral neuropathy
These include how severe the deficiency is, the persons health needs, and how the shot is given
Brief temperature excursions (under 2 hours at moderate temperatures) generally do not damage GLP-1 medications significantly
The consistency of the safety profile across short-term and long-term trials suggests that AOD-9604 does not produce cumulative toxicity or delayed adverse effects that emerge only with chronic administration